These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8890630)

  • 1. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
    Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
    Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk pathway: cyclin-dependent kinases and cyclin-dependent kinase inhibitors.
    Gitig DM; Koff A
    Methods Mol Biol; 2000; 142():109-23. PubMed ID: 10806617
    [No Abstract]   [Full Text] [Related]  

  • 3. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the cdk inhibitor p27 and its deregulation in cancer.
    Slingerland J; Pagano M
    J Cell Physiol; 2000 Apr; 183(1):10-7. PubMed ID: 10699961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cdk inhibiting proteins].
    Tomoda K; Kato J
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1407-13. PubMed ID: 9309133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kip1 meets SKP2: new links in cell-cycle control.
    Amati B; Vlach J
    Nat Cell Biol; 1999 Aug; 1(4):E91-3. PubMed ID: 10559929
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation.
    Durand B; Gao FB; Raff M
    EMBO J; 1997 Jan; 16(2):306-17. PubMed ID: 9029151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer.
    Desdouets C; Bréchot C
    Pathol Biol (Paris); 2000 Apr; 48(3):203-10. PubMed ID: 10858954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Johnson D; Frame MC; Wyke JA
    Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
    Sgambato A; Cittadini A; Faraglia B; Weinstein IB
    J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.
    Philipp-Staheli J; Payne SR; Kemp CJ
    Exp Cell Res; 2001 Mar; 264(1):148-68. PubMed ID: 11237531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27 expression and gastric carcinoma.
    Mori M; Mimori K; Shiraishi T; Tanaka S; Ueo H; Sugimachi K; Akiyoshi T
    Nat Med; 1997 Jun; 3(6):593. PubMed ID: 9176477
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel protein may identify more aggressive prostate cancers.
    Gottlieb S
    BMJ; 1998 Sep; 317(7160):701. PubMed ID: 9840998
    [No Abstract]   [Full Text] [Related]  

  • 16. Replicative senescence of human primary cells--molecules and mechanisms.
    Wagner M; Jansen-Dürr P
    Exp Gerontol; 2000 Sep; 35(6-7):729-32. PubMed ID: 11053663
    [No Abstract]   [Full Text] [Related]  

  • 17. Promiscuous activation and cell cycle entry in T cells from autoimmune animals.
    Moore JK; Bellgrau D
    Transplant Proc; 1999 May; 31(3):1606-10. PubMed ID: 10331020
    [No Abstract]   [Full Text] [Related]  

  • 18. [ATIP, a novel superfamily of microtubule-associated proteins].
    Molina A; Rodrigues-Ferreira S; Di Tommaso A; Nahmias C
    Med Sci (Paris); 2011 Mar; 27(3):244-6. PubMed ID: 21447291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of cell cycle by the p27 Cdk-inhibitor].
    Toyoshima H
    Tanpakushitsu Kakusan Koso; 1996 Sep; 41(12 Suppl):1732-6. PubMed ID: 8890630
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.